Leveraging AI and LLM
Improve and accelerate key capabilities
We leverage 2 independent AI models to monitor and select assets across multiple data lakes and type as well as support scientific and commercial diligence efforts, generate study reports etc.
Our models capitalize on more than 10 TB of human patient data, across hundreds of human disease phenotypes in order to discover novel - and now patented - drug mechanisms and matter
The augmented market intelligence and diligencing LLM agent is built on SDC proprietary and open-source data - local private architecture ensures confidentiality
The AI data types include:
PoS – commercial and biological/clinical, PoS Distributions, ICER, QALY, MoU Validation, Modality, Pre-Clinical Data, Timeline, Capital Requirements, Sponsor Track Record, and
Correlation with other Programs
SATIS
The Synkrino AI Target ID Stack is a patented AI system that discovers and validates novel drug targets and drug mechanisms directly from human patient data
SMILES
The SDC Market Intelligence LLM Stack, generates scientific and market diligence reports on SDC pipeline assets. Projects market exits